Merck

Merck develops medicines, vaccines, biologic therapies, consumer care and animal health products. Read more

78,717 Followers on Owler
78,717 Followers on Owler
78,717 Followers on Owler
78,717 Followers on Owler

Merck

Merck develops medicines, vaccines, biologic therapies, consumer care and animal health products. Read more

Kenneth C. Frazier's photo - Chairman & CEO of Merck

Chairman & CEO

Kenneth C. Frazier

CEO Approval Rating

86/100

Founded:

1891

Status:

PublicIndependent CompanyNYSEMRK

MERCK TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Novartis is perceived as one of Merck's biggest rivals. Novartis was founded in 1996, and its headquarters is in Basel, Basel-City. Like Merck, Novartis also works within the Pharmaceuticals field. Novartis has 41,000 more employees than Merck.

Pfizer is one of Merck's top rivals. Pfizer is a Public company that was founded in 1849 in New York, New York. Like Merck, Pfizer also competes in the Pharmaceuticals sector. Compared to Merck, Pfizer has 9,500 more employees.

Roche is Merck's #3 rival. Roche is a Public company that was founded in Basel, Basel-Country in 1896. Like Merck, Roche also operates in the Pharmaceuticals sector. Roche has 31,000 more employees vs. Merck.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is GSK a competitor of Merck?

Merck Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$48B

Merck's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 34.4B. Over the last four quarters, Merck's revenue has grown by 11.1%. Specifically, in Q1 2021's revenue was $12.1B; in Q4 2020, it was $12.5B; in Q3 2020, it was $12.6B; in Q2 2020, Merck's revenue was $10.9B.

Merck Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Alydia Health, Inc.

Mar 2021

Source »
$215M
Alydia is a California-based medical device company that develops and commercializes hemorrhage control devices for the treatment of postpartum uterine bleeding.
Pandion Therapeutics, Inc.

Feb 2021

Source »
$1.9B
Pandion is a biotechnology company that develops and commercializes antibody therapeutics for the treatment of autoimmune and inflammatory diseases.
OncoImmune, Inc.

Nov 2020

Source »
$425M
OncoImmune is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer and autoimmune diseases.
VelosBio, Inc.

Nov 2020

Source »
$2.8B
VelosBio is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
Themis Bioscience GmbH

May 2020

Source »
undisclosed
Themis is a biopharmaceutical company that develops and commercializes immunomodulation therapies for the treatment of infectious diseases and cancer.

These are all the companies that Merck has acquired. Merck has acquired 22 companies and its latest acquisition was Alydia Health, Inc. in Mar 2021. Alydia is a California-based medical device company that develops and commercializes hemorrhage control devices for the treatment of postpartum uterine bleeding.

Merck Funding History

No recent funding data found related to Merck

Merck Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Serimmune is an immune intelligence company that provides human immunity mapping and antigen stimulation solutions for research applications.
$12M
Aug 26, 2020
Equity
-
SAB Biotherapeutics is a clinical-stage biopharmaceutical company that develops and commercializes immunotherapies to treat infectious diseases.
$14M
Jul 16, 2020
Series B
-
Yumanity Therapeutics develops and commercializes drug-based therapies for the treatment of neurodegenerative diseases.
$21.6M
Jun 18, 2020
Series C
-
Themis is a biopharmaceutical company that develops and commercializes immunomodulation therapies for the treatment of infectious diseases and cancer.
$44M
Sep 17, 2019
Series D
May 01, 2020
Navigating Cancer develops a patient relationship management platform that offers personalized care management services for patients and oncologists.
$26M
Mar 18, 2019
Series D
-

These are all the companies that Merck has invested in. Merck has invested 22 companies and its latest investment was Alydia Health, Inc. in Mar 2021. Alydia is a California-based medical device company that develops and commercializes hemorrhage control devices for the treatment of postpartum uterine bleeding.

Merck News

May 6, 2021FierceBiotechIT

Merck takes $170M charge on abandoned COVID-19 drug

Merck takes $170M charge on abandoned COVID-19 drug ntaylor Thu, 05/06/2021 - 08:49... See more »
May 6, 2021Markets Insider

Fusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer Study

Fusion Pharmaceuticals Inc (NASDAQ: FUSN) has entered into a clinical trial collaboration with Merck ... See more »
May 3, 2021MarketScreener

Hosts Organon Investor Day Outlining New Company's Vision, Focus and Business Model for Sustained Growth

(marketscreener.com) Standalone company positioned to deliver low to mid-single digit revenue growth ... See more »
April 30, 2021BioSpace

Merck Announces First-Quarter 2021 Financial Results

First-Quarter 2021 Sales Were $12.1 Billion, In-Line with First-Quarter 2020; Excluding the Impact fr... See more »
April 29, 2021Channel NewsAsia

New era begins at Merck as pandemic cuts Q1 sales, profit

Merck is entering a new era, with sweeping changes across its executive suite and the spinoff off its... See more »
April 29, 2021MarketScreener

1Q21 Merck Other Financial Disclosures

(marketscreener.com) Merck & Co., Inc. Financial Highlights Package First Quarter...https://www.marke... See more »
April 29, 2021Homeland Preparedness News

Merck announces voluntary licensing agreements with five Indian generics manufacturers to boost access to COVID-19 therapeutic

Merck has reached voluntary licensing agreements with five Indian generics manufacturers to produce m... See more »

Merck Press Releases

April 28, 2021StreetInsider

Merck Manuals Clears Up Common Myths About Acne

KENILWORTH, N.J., April 28, 2021 /PRNewswire/ -- Eight in 10 Americans will have acne at some point i... See more »
April 14, 2021Business Wire

Merck Expands Safer Childbirth Cities Initiative to 20th Community-Led Project Advancing Maternal Health Equity During Black Maternal Health Week

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck Expands Safer Childbirth Cities Initiative to 20th Community... See more »
April 6, 2021Business Wire

Organon Announces Proposed Senior Notes Offering

KENILWORTH, N.J.--(BUSINESS WIRE)--Organon Announces Proposed Senior Notes Offering... See more »
February 12, 2021News n Releases

Starpharma signs research agreement with MSD

MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co.... See more »
December 28, 2020PressReleasePoint

Lynparza approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers

AstraZeneca and MSD's Lynparza (olaparib) has been approved in Japan for the treatment of advanced ov... See more »
December 18, 2020Business Wire

Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics Announces Collaboration with Merck to Develop Novel Dr... See more »

Merck Videos

Social Media

Merck Headquarters

2000 Galloping Hill Road

Kenilworth, New Jersey07033

1-908-740-4000

Driving Directions »

Trending Companies

Merck Summary

ABOUT

Overview

Merck & Co., Inc. (NYSE: MRK) develops medicines, vaccines, biologic therapies, consumer care, and animal health products. It is known as Merck, Sharp & Dohme (MSD) outside of the US and Canada and it is an American pharmaceutical company. It was esta...

CEO

Merck's Chairman & CEO, Kenneth C. Frazier, currently has an approval rating of 86%. Merck's primary competitors are Novartis, Pfizer & Roche.

Website

merck.com

Frequently Asked Questions about Merck

  1. When was Merck founded?

    Merck was founded in 1891
  2. Who is Merck's CEO?

    Merck's CEO is Kenneth C. Frazier
  3. How much revenue does Merck generate?

    Merck generates $48B in revenue
  4. How much funding does Merck have?

    Merck has historically raised $0 in funding
  5. Where is Merck's headquarters?

    Merck's headquarters is in Kenilworth New Jersey, USA
  1. How many employees does Merck have?

    Merck has 69,000 employees
  2. What sector does Merck operate in?

    Merck is in Pharmaceuticals
  3. Who are Merck's competitors?

    Merck's top competitors are Novartis, Pfizer, Roche
  4. Who has Merck invested in?

    Merck's has invested in companies such as Serimmune, SAB Biotherapeutics, Yumanity